UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects

Arteriosclerosis, thrombosis, and vascular biology, 2001-12, Vol.21 (12), p.1962-1968

2001

Volltextzugriff (PDF)

Components of the Fibrinolytic System Are Differently Altered in Moderate and Severe Hypothyroidism

The journal of clinical endocrinology and metabolism, 2001-02, Vol.86 (2), p.732-737

2001

Volltextzugriff (PDF)

Indications and Limits of Ultrasound-Guided Cytology in the Management of Nonpalpable Thyroid Nodules

The journal of clinical endocrinology and metabolism, 1999-01, Vol.84 (1), p.24-28

1999

Volltextzugriff (PDF)

Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia

Arteriosclerosis, thrombosis, and vascular biology, 1996-06, Vol.16 (6), p.763-772

1996

Volltextzugriff (PDF)

Survival and Therapeutic Modalities in Patients with Bone Metastases of Differentiated Thyroid Carcinomas

The journal of clinical endocrinology and metabolism, 2001-04, Vol.86 (4), p.1568-1573

2001

Volltextzugriff (PDF)

Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas

The journal of clinical endocrinology and metabolism, 2001-04, Vol.86 (4), p.1568-1573

2001

Volltextzugriff (PDF)

Relationship between thyroid hormones and plasma D-dimer levels

Thrombosis and haemostasis, 1998-01, Vol.79 (1), p.99-103

1998

Volltextzugriff (PDF)

Low free-thyroxine levels are a risk factor for subclinical atherosclerosis in euthyroid hyperlipidemic patients

European journal of cardiovascular prevention and rehabilitation, 1999-10, Vol.6 (5), p.327-331

1999

Volltextzugriff (PDF)

Liver fibrosis in overweight patients

Gastroenterology (New York, N.Y. 1943), 2000-06, Vol.118 (6), p.1117-1123

2000

Volltextzugriff (PDF)

Prevalence of Lymphocytic Infiltrate in 1400 Pituitary Adenomas

Endocrine Journal, 1998, Vol.45(3), pp.357-361

1998

Volltextzugriff (PDF)

Common promoter C516T polymorphism in the ApoB gene is an independent predictor of carotid atherosclerotic disease in subjects presenting a broad range of plasma cholesterol levels

Arteriosclerosis, thrombosis, and vascular biology, 2004-11, Vol.24 (11), p.2192-2195

2004

Volltextzugriff (PDF)

A human TSH-secreting adenoma: endocrine, biochemical and morphological studies. Evidence of somatostatin receptors by using quantitative autoradiography. Clinical and biological improvement by SMS 201-995 treatment

Acta endocrinologica (Copenhagen), 1991-05, Vol.124 (4), p.479-486

1991

Volltextzugriff (PDF)

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

BMC gastroenterology, 2006-02, Vol.6 (1), p.6-6, Article 6

2006

Volltextzugriff (PDF)

Familial acromegaly: a specific clinical entity--further evidence from the genetic study of a three-generation family

European journal of endocrinology, 1995-10, Vol.133 (4), p.451-456

1995

Volltextzugriff (PDF)

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

BMC gastroenterology, 2006-11, Vol.6 (1), p.34-34, Article 34

2006

Volltextzugriff (PDF)

Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism

The journal of clinical endocrinology and metabolism, 2001-02, Vol.86 (2), p.732-737

2001

Volltextzugriff (PDF)

Common polymorphism in the MTP promoter attenuates the dyslipidemic and proatherogenic effects of excess body weight

Arteriosclerosis, thrombosis, and vascular biology, 2004-08, Vol.24 (8), p.e143

2004

Volltextzugriff (PDF)

Magnitude of HDL cholesterol variation after high-dose atorvastatin is genetically determined at the LDL receptor locus in patients with homozygous familial hypercholesterolemia

Arteriosclerosis, thrombosis, and vascular biology, 2003-11, Vol.23 (11), p.2078-2082

2003

Volltextzugriff (PDF)

A comprehensive description of muscle symptoms associated with lipid-lowering drugs

Cardiovascular drugs and therapy, 2003-09, Vol.17 (5-6), p.459-465

2003

Volltextzugriff (PDF)

Interrelationships between postprandial lipoprotein B:CIII particle changes and high-density lipoprotein subpopulation profiles in mixed hyperlipoproteinemia

Metabolism, clinical and experimental, 1999, Vol.48 (1), p.60-67

1999

Volltextzugriff (PDF)

Secondary thyroidectomy in patients with prior thyroid surgery for benign disease: A study of 203 cases

Surgery, 1999-09, Vol.126 (3), p.479-483

1999

Volltextzugriff (PDF)

Estrogens and progestins in postmenopausal women: influence on lipid parameters and cardiovascular risk

Hormone research, 1995-01, Vol.43 (1-3), p.100-103

1995

Volltextzugriff (PDF)

Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia

Atherosclerosis, 2001-02, Vol.154 (2), p.421-427

2001

Volltextzugriff (PDF)

Serum neuron-specific enolase in patients with pituitary adenoma

Clinical chemistry (Baltimore, Md.), 1997-03, Vol.43 (3), p.540-541

1997

Volltextzugriff (PDF)

L’ézétimibe comme complément des statines ?

La Presse médicale (1983), 2006-03, Vol.35 (3), p.487-494

2006

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects

Components of the Fibrinolytic System Are Differently Altered in Moderate and Severe Hypothyroidism

Indications and Limits of Ultrasound-Guided Cytology in the Management of Nonpalpable Thyroid Nodules

Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia

Survival and Therapeutic Modalities in Patients with Bone Metastases of Differentiated Thyroid Carcinomas

Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas

Relationship between thyroid hormones and plasma D-dimer levels

Low free-thyroxine levels are a risk factor for subclinical atherosclerosis in euthyroid hyperlipidemic patients

Liver fibrosis in overweight patients

Prevalence of Lymphocytic Infiltrate in 1400 Pituitary Adenomas

Common promoter C516T polymorphism in the ApoB gene is an independent predictor of carotid atherosclerotic disease in subjects presenting a broad range of plasma cholesterol levels

A human TSH-secreting adenoma: endocrine, biochemical and morphological studies. Evidence of somatostatin receptors by using quantitative autoradiography. Clinical and biological improvement by SMS 201-995 treatment

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

Familial acromegaly: a specific clinical entity--further evidence from the genetic study of a three-generation family

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism

Common polymorphism in the MTP promoter attenuates the dyslipidemic and proatherogenic effects of excess body weight

Magnitude of HDL cholesterol variation after high-dose atorvastatin is genetically determined at the LDL receptor locus in patients with homozygous familial hypercholesterolemia

A comprehensive description of muscle symptoms associated with lipid-lowering drugs

Interrelationships between postprandial lipoprotein B:CIII particle changes and high-density lipoprotein subpopulation profiles in mixed hyperlipoproteinemia

Secondary thyroidectomy in patients with prior thyroid surgery for benign disease: A study of 203 cases

Estrogens and progestins in postmenopausal women: influence on lipid parameters and cardiovascular risk

Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia

Serum neuron-specific enolase in patients with pituitary adenoma

L’ézétimibe comme complément des statines ?

Suchergebnisse filtern